Journal
KOREAN JOURNAL OF RADIOLOGY
Volume 20, Issue 1, Pages 134-147Publisher
KOREAN RADIOLOGICAL SOC
DOI: 10.3348/kjr.2018.0356
Keywords
Pharmacovigilance and Risk Assessment Committee; Ministry of Food and Drug Safety in Korea; Deposition mechanism; Thermodynamic stability; Chelating ligand; Gadoilnium; Brain deposition
Funding
- Konkuk University
Ask authors/readers for more resources
Gadolinium-based contrast agents (GBCAs) are commonly used for enhancement in MR imaging and have long been considered safe when administered at recommended doses. However, since the report that nephrogenic systemic fibrosis is linked to the use of GBCAs in subjects with severe renal diseases, accumulating evidence has suggested that GBCAs are not cleared entirely from our bodies; some GBCAs are deposited in our tissues, including the brain. GBCA deposition in the brain is mostly linked to the specific chelate structure of the GBCA: linear GBCAs were responsible for brain deposition in almost all reported studies. This review aimed to summarize the current knowledge about GBCA brain deposition and discuss its clinical implications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available